Skip to main content
Journal cover image

Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Publication ,  Journal Article
Kim, BJ; Ying, G-S; Huang, J; Levy, NE; Maguire, MG; CATT Research Group,
Published in: Am J Ophthalmol
July 2014

PURPOSE: To evaluate transient, large visual acuity (VA) decreases, termed sporadic vision loss, during anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration (AMD). DESIGN: Cohort within a randomized clinical trial. METHODS: setting: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). study population: Total of 1185 CATT patients. main outcome measures: Incidence of sporadic vision loss and odds ratio (OR) for association with patient and ocular factors. Sporadic vision loss was a decline of ≥15 letters from the previous visit, followed by a return at the next visit to no more than 5 letters worse than the visit before the VA loss. RESULTS: There were 143 sporadic vision loss events in 122 of 1185 patients (10.3%). Mean VA at 2 years for those with and without sporadic vision loss was 58.5 (∼20/63) and 68.4 (∼20/40) letters, respectively (P < .001). Among patients treated pro re nata, no injection was given for 27.6% (27/98) of sporadic vision loss events. Multivariate analysis demonstrated that baseline predictors for sporadic vision loss included worse baseline VA (OR 2.92, 95% confidence interval [CI]:1.65-5.17 for ≤20/200 compared with ≥20/40), scar (OR 2.21, 95% CI:1.22-4.01), intraretinal foveal fluid on optical coherence tomography (OR 1.80, 95% CI:1.11-2.91), and medical history of anxiety (OR 1.90, 95% CI:1.12-3.24) and syncope (OR 2.75, 95% CI:1.45-5.22). Refraction decreased the likelihood of sporadic vision loss (OR 0.62, 95%CI: 0.42-0.91). CONCLUSIONS: Approximately 10% of CATT patients had sporadic vision loss. Baseline predictors included AMD-related factors and factors independent of AMD. These data are relevant for clinicians in practice and those involved in clinical trials.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Ophthalmol

DOI

EISSN

1879-1891

Publication Date

July 2014

Volume

158

Issue

1

Start / End Page

128 / 135.e10

Location

United States

Related Subject Headings

  • Wet Macular Degeneration
  • Visual Acuity
  • Vision Tests
  • Vision Disorders
  • Vascular Endothelial Growth Factor A
  • Tomography, Optical Coherence
  • Ranibizumab
  • Prospective Studies
  • Ophthalmology & Optometry
  • Odds Ratio
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kim, B. J., Ying, G.-S., Huang, J., Levy, N. E., Maguire, M. G., & CATT Research Group, . (2014). Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol, 158(1), 128-135.e10. https://doi.org/10.1016/j.ajo.2014.04.004
Kim, Benjamin J., Gui-Shuang Ying, Jiayan Huang, Nicole E. Levy, Maureen G. Maguire, and Maureen G. CATT Research Group. “Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).Am J Ophthalmol 158, no. 1 (July 2014): 128-135.e10. https://doi.org/10.1016/j.ajo.2014.04.004.
Kim BJ, Ying G-S, Huang J, Levy NE, Maguire MG, CATT Research Group. Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol. 2014 Jul;158(1):128-135.e10.
Kim, Benjamin J., et al. “Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).Am J Ophthalmol, vol. 158, no. 1, July 2014, pp. 128-135.e10. Pubmed, doi:10.1016/j.ajo.2014.04.004.
Kim BJ, Ying G-S, Huang J, Levy NE, Maguire MG, CATT Research Group. Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol. 2014 Jul;158(1):128-135.e10.
Journal cover image

Published In

Am J Ophthalmol

DOI

EISSN

1879-1891

Publication Date

July 2014

Volume

158

Issue

1

Start / End Page

128 / 135.e10

Location

United States

Related Subject Headings

  • Wet Macular Degeneration
  • Visual Acuity
  • Vision Tests
  • Vision Disorders
  • Vascular Endothelial Growth Factor A
  • Tomography, Optical Coherence
  • Ranibizumab
  • Prospective Studies
  • Ophthalmology & Optometry
  • Odds Ratio